Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects

American Journal of Clinical Nutrition

Volumn 84, Issue 1, 2006, Pages 54-62

  Vega López, Sonia ^a   Ausman, Lynne M ^a   Jalbert, Susan M ^a   Erkkilä, Arja T ^b   Lichtenstein, Alice H ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cardiovascular disease; Cholesteryl ester transfer protein; Glucose; HDL cholesterol; Insulin; LDL cholesterol; Lipoproteins; Palm oil; Partially hydrogenated soybean oil; Phospholipid transfer protein; trans fatty acids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PALM OIL; PHOSPHOLIPID TRANSFER PROTEIN; RAPESEED OIL; SOYBEAN OIL; APOLIPOPROTEIN; CANOLA OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; TRIACYLGLYCEROL; VEGETABLE OIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTERIFICATION; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; HUMAN; HYPERLIPIDEMIA; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; MALE; RANDOMIZED CONTROLLED TRIAL; BLOOD; CARDIOVASCULAR DISEASE; CROSSOVER PROCEDURE; DIET THERAPY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYDROGENATION; METABOLISM; MIDDLE AGED; RISK FACTOR;

BRASSICA NAPUS VAR. NAPUS; GLYCINE MAX;

AGED; APOLIPOPROTEINS; APOLIPOPROTEINS B; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYDROGENATION; HYPERLIPIDEMIAS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PLANT OILS; RISK FACTORS; SOYBEAN OIL; TRIGLYCERIDES;

EID: 33747389408     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.1.54     Document Type: Article

References (71)

1. Krauss RM, Eckel RH, Howard B, et al. AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. J Nutr 2001;131:132-46.
2. NCEP Expert Panel. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. McGandy RB, Hegsted DM, Myers ML. Use of semisynthetic fats in determining effects of specific dietary fatty acids on serum lipids in man. Am J Clin Nutr 1970;23:1288-98.
4. Keys A, Anderson JT, Grande F. Serum cholesterol response to change in the diet. Metabolism 1965;14:747-58.
5. USDA, Economic Research Service. Food Consumption (Per Capita) Data System, Food Availability. Updates 1 February 2004. Internet: http://www.ers.usda.gov/data/foodconsumption/foodavailindex.htm (accessed 14 December 2005).
6. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995;24:308-15.
7. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-9.
8. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997;314:112-7.
9. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high density and low density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-45.
10. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999;340:1933-40.
11. Ash M, Dohlman E. Oil crops situation and outlook yearbook/OCS-2005/March 2005. Washington, DC: Market and Trade Economics Division, Economic Research Service, US Department of Agriculture, 2005:91.
12. Edem DO. Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review. Plant Foods Hum Nutr 2002;57:319-41.
13. USDA/Agricultural Research Service, Nutrient Data Laboratory. USDA National Nutrient Database for Standard Reference, Release 18. Updated 23 September 2005. Internet: http://www.nal.usda.gov/fnic/foodcomp (accessed 30 November 2005).
14. Allison DB, Egan SK, Barraj LM, Caughman C, Infante M, Heimbach JT. Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999;99:166-74.
15. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146-55.
16. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 1994;59:861-8.
17. Clevidence BA, Judd JT, Schaefer EJ, et al. Plasma (a) levels in men and women consuming diets enriched in saturated, cis-, or transmonounsaturated fatty acids. Arterioscler Thromb Vasc Biol 1997;17:1657-61.
18. Judd JT, Baer DJ, Clevidence BA, et al. Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets. Am J Clin Nutr 1998;68:768-77.
19. Lichtenstein AH, Ausman LM, Carrasco WV, et al. Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans. Arterioscler Thromb 1994;14:549-56.
20. Lichtenstein AH, Ausman LM, Jalbert SM, et al. Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects. J Lipid Res 2002;43:264-73.
21. Havel RJ, Eder HA, Bragdon JH. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
22. McNamara JR, Schaefer EJ. Automated enzymatic conventionalized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8.
23. 2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
24. Nguyen T, Warnick GR. Improved methods for separation of total HDL and subclasses. Clin Chem 1989;35:1086-94.
25. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein B determined with a conventionalized reformulated immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996;42:515-23.
26. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996;42:507-14.
27. Parra HJ, Mezdour H, Ghalim N, Bard J-M, Fruchart J-C. Differential electroimmunoassay of human Lp A-I lipoprotein particles on ready-touse plates. Clin Chem 1990;36:1431-5.
28. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels. The Framingham Offspring Study. Circulation 1993;87:1135-41.
29. Vidgren HM, Louheranta AM, Agren JJ, Schwab US, Uusitupa MI. Divergent incorporation of dietary trans fatty acids in different serum lipid fractions. Lipids 1998;33:955-62.
30. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic, and diabetic rats. Diabetes 1963;12:115-26.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
32. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.
33. Dobiášová M, Frohlich JJ. Assays of lecithin cholesteryl acyltransferase (LCAT). In: Ordovas JM, ed. Lipoprotein protocols. Totowa, NJ: Humana Press, 1998:217-30.
34. Dobiášová M, Frohlich JJ. Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol. Physiol Res 1998;47:387-97.
35. Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986;32:283-6.
36. C) phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta 1982;712:444-52.
37. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993;268:4032-6.
38. Pussinen P, Jauhiainen M, Metso J, Tyynelä J, Ehnholm C. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res 1995;36:975-85.
39. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-6.
40. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001;20:5-19.
41. Lichtenstein AH. Dietary fat and cardiovascular disease risk: quantity or quality? J Womens Health 2003;12:109-14.
42. Mattson F, Grundy S. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.
43. Denke MA, Grundy SM. Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr 1992;56:895-8.
44. Müller H, Jordal O, Kierulf P, Kirkhus B, Pedersen JI. Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavorable effects on serum lipoproteins. Lipids 1998;33:879-87.
45. Bautista LE, Herrán OF, Serrano C. Effects of palm oil and dietary cholesterol on plasma lipoproteins: results from a dietary crossover trial in free-living subjects. Eur J Clin Nutr 2001;55:748-54.
46. Cater NB, Heller HJ, Denke MA. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr 1997;65:41-5.
47. Marzuki A, Arshad F, Razak TA, Jaarin K. Influence of dietary fat on plasma lipid profiles of Malaysian adolescents. Am J Clin Nutr 1991;53(suppl):1010S-4S.
48. Choudhury N, Tan L, Truswell AS. Comparison of palmolein and olive oil: effects on plasma lipids and vitamin E in young adults. Am J Clin Nutr 1995;61:1043-51.
49. Zhang J, Ping W, Chunrong W, Shou CX, Keyou G. Nonhypercholesterolemic effects of a palm oil diet in Chinese adults. J Nutr 1997;127:509S-13S.
50. Zhang J, Wang CR, Xue AN, Ge KY. Effects of red palm oil on serum lipids and plasma carotenoid levels in Chinese male adults. Biomed Environm Sci 2003;16:348-54.
51. Hayes KC, Pronczuk A, Lindsey S, Diersen-Schade D. Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates. Am J Clin Nutr 1991;53:491-8.
52. Khosla P, Hajri T, Pronczuk A, Hayes KC. Decreasing dietary lauric and myristic acids improves plasma lipids more favorably than decreasing dietary palmitic acid in rhesus monkeys fed AHA step I type diets. J Nutr 1997;127:525S-30S.
53. Sundram K, Hayes KC, Siru OH. Dietary palmitic acid results in lower serum cholesterol than does a lauric-myristic acid combination in normolipemic humans. Am J Clin Nutr 1994;59:841-6.
54. Tholstrup T, Marckmann P, Jespersen J, Sandstrom B. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr 1994;59:371-7.
55. de Roos NM, Schouten EG, Katan MB. Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids. J Nutr 2001;131:242-5.
56. Lichtenstein AH, Jauhiainen M, McGladdery S, et al. Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism. J Lipid Res 2001;42:597-604.
57. Yu S, Yarnell JWG, Sweetnam P, Bolton CH. High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study. Atherosclerosis 2003;166:331-8.
58. Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP. Associations of HDL, HDL2, and HDL3 cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project. Prev Med 2000;31:346-56.
59. Morgan JM, Carey C, Lincoff A, Capuzzi DM. High-density lipoprotein subfractions and risk of coronary artery disease. Curr Atheroscler Rep 2004;6:359-65.
60. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108-13.
61. Mensink RP, Hornstra G. The proportion of trans monounsaturated fatty acids in serum triacylglycerols or platelet phospholipids as an objective indicator of their short-term intake in healthy men. Br J Nutr 1995;73:605-12.
62. Raatz SK, Bibus D, Thomas W, Kris-Etherton PM. Total fat intake modifies plasma fatty acid composition in humans. J Nutr 2001;131:231-4.
63. Lichtenstein AH, Erkkilä AT, Lamarche B, Schwab US, Jalbert SM, Ausman LM. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 2003;171:97-107.
64. Goyens PLL, Spilker ME, Zock PL, Katan MB, Mensink RP. Compartmental modeling to quantify α-linolenic acid conversion after longer term intake of multiple tracer boluses. J Lipid Res 2005;46:1474-83.
65. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003;77:319-25.
66. Salmerón J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-26.
67. Lovejoy J, Champagne C, Smith S, et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metabolism 2001;50:86-92.
68. Lovejoy JC, Smith SR, Champagne CM, et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002;25:1283-8.
69. Jensen J, Bysted A, Dawids S, Hermansen K, Hølmer G. The effect of palm oil, lard, and puff-pastry margarine on postprandial lipid and hormone responses in normal-weight and obese young women. Br J Nutr 1999;82:469-79.
70. Vessby B, Uusitupa MI, Hermansen K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 2001;44:312-9.
71. Louheranta AM, Turpeinen AK, Vidgren HM, Schwab US, Uusitupa MI. A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 1999;48:870-5.